LYRA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 118226 min ago

@ $4.78

Wydano: 14 vas. 2024 @ 22:33

Zwrot: -89.09%

Poprzedni sygnał: vas. 9 - 21:49

Poprzedni sygnał: Sprzedaż

Zwrot: 2.36 %

Live Chart Being Loaded With Signals

Commentary (6 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	107.57M
Średni wolumen	373 395
Kapitalizacja rynkowa	31.16M
EPS	$0 ( 2024-04-03 )
Następna data zysków	( $-0.260 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.410
ATR14	$0.00600 (1.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Waksal Harlan	Buy	275 000	Common Stock
2024-03-18	Palasis Maria	Buy	500 000	Stock Option
2024-01-30	Bishop John E	Buy	200 000	Stock Options
2024-01-30	Nieman Richard	Buy	200 000	Stock Options
2024-01-30	Cavalier Jason	Buy	200 000	Stock Options

INSIDER POWER
100.00
Last 92 transactions
Buy: 35 062 945 \| Sell: 0

Wolumen Korelacja

Długi: 0.52 (weak)

Krótki: -0.43 (neutral)

Signal:(50.796) Neutral

Lyra Therapeutics Inc Korelacja

10 Najbardziej pozytywne korelacje
BCPC	0.85
NVNO	0.819
FICS	0.815
GRNQ	0.809
CD	0.802

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lyra Therapeutics Inc Korelacja - Waluta/Towar

0.64
( weak )

0.68
( moderate )

0.00
( neutral )

0.50
( neutral )

-0.57
( weak negative )

Lyra Therapeutics Inc Finanse

Annual	2023
Przychody:	$1.56M
Zysk brutto:	$1.28M (82.16 %)
EPS:	$-1.260

FY	2023
Przychody:	$1.56M
Zysk brutto:	$1.28M (82.16 %)
EPS:	$-1.260

FY	2022
Przychody:	$1.36M
Zysk brutto:	$296 000 (21.72 %)
EPS:	$-1.830

FY	2021
Przychody:	$285 000
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.35

Financial Reports:

No articles found.

Lyra Therapeutics Inc

Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.

Aktualne aktualizacje dla Lyra Therapeutics Inc [LYRA]

Upcoming Earnings Alert